C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice

BACKGROUND: Pulmonary fibrosis has high rates of mortality and morbidity; however, no effective pharmacological therapy has been established. C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, selectively binds to the transmembrane guanylyl cyclase (GC)-B receptor and exer...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Respir Res
Glavni autori: Kimura, Toru, Nojiri, Takashi, Hino, Jun, Hosoda, Hiroshi, Miura, Koichi, Shintani, Yasushi, Inoue, Masayoshi, Zenitani, Masahiro, Takabatake, Hiroyuki, Miyazato, Mikiya, Okumura, Meinoshin, Kangawa, Kenji
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4761143/
https://ncbi.nlm.nih.gov/pubmed/26895702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0335-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items